Legionellosis

 

 Buy Article Permissions and Reprints

ABSTRACT

Community-acquired legionnaires' disease (CALD) has dramatically increased in the Legionella urinary antigen (LUA) era. However, its incidence in each country depends on the specific techniques used for the diagnosis of LD and the mandatory reporting of cases to the local health surveillance system. Moreover, the most recent studies have demonstrated that no clinical data are discriminative enough for the diagnosis of LD. Clinical differences have been observed in sporadic and outbreak-reported cases demonstrating that the earlier the diagnosis of Legionella infection, the more nonspecific the clinical appearance. Fluoroquinolones are the most efficacious drugs against Legionella. The combination of these drugs with azithromycin seems to be promising in the treatment of patients with severe LD. Although outbreaks of LD will continue, the most important objective of the public health authorities should be to reduce their number and size.

REFERENCES

• 1 Sopena N, Sabrià M, Pedro-Botet M L et al.. Prospective study of community-acquired pneumonia of bacterial etiology in adults.  Eur J Clin Microbiol Infect Dis. 1999;  18 852-858
  CrossrefPubMedGoogle Scholar
• 2 Vergis E N, Akbas E, Yu V L. Legionella as a cause of severe pneumonia.  Sem Respir Crit Care Med. 2000;  21 295-304
  PubMedGoogle Scholar
• 3 Lepine L A, Jernigan D B, Butler J C et al.. A recurrent outbreak of nosocomial legionnaires' disease detected by urinary antigen testing: evidence for long-term colonization of a hospital plumbing system.  Infect Control Hosp Epidemiol. 1998;  19 905-910
  PubMedGoogle Scholar
• 4 Kool J L, Fiore A E, Kioski C M et al.. More than 10 years of unrecognized nosocomial transmission of legionnaires' disease among transplant patients.  Infect Control Hosp Epidemiol. 1998;  19 898-904
  PubMedGoogle Scholar
• 5 Sabrià M, Mòdol J M, Garcia-Núñez M et al.. Environmental cultures and hospital-acquired legionnaires' disease: a five-year prospective study in twenty hospitals in Catalonia. Spain.  Infect Control Hosp Epidemiol. 2004;  25 1072-1076
  PubMedGoogle Scholar
• 6 Marston B J, Plouffle J F, File T M et al.. Incidence of community acquired pneumonia requiring hospitalization.  Arch Intern Med. 1997;  157 1709-1718
  CrossrefPubMedGoogle Scholar
• 7 Benin A L, Benson R F, Besser R E. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis.  Clin Infect Dis. 2002;  35 1039-1046
  CrossrefPubMedGoogle Scholar
• 8 Joseph C A. and The European Working Group for Legionella Infection . Legionnaires' disease in Europe 2000-2002.  Epidemiol Infect. 2004;  132 417-424
  CrossrefPubMedGoogle Scholar
• 9 Departament de Sanitat i Seguretat Social . Resum de malalties de declaració obligatòria a Catalunya durant l'any 2002.  Bulletí Epidemiològic de Catalunya. 2003;  24 121-132
  PubMedGoogle Scholar
• 10 Fernández N, Gudiol F, Domínguez J, Ausina V, Sopena N. Legionellosis: clinical manifestations, diagnosis and treatment.  Med Clin (Barc). 2002;  119(Suppl 2) 2-32
  PubMedGoogle Scholar
• 11 Mulazimoglu L, Yu V L. Can legionnaires' disease be diagnosed by clinical criteria? A critical review.  Chest. 2001;  120 1049-1053
  CrossrefPubMedGoogle Scholar
• 12 García-Fulgueiras A, Navarro C, Fenoll D et al.. Legionnaires' disease outbreak in Murcia, Spain.  Emerg Infect Dis. 2003;  9 915-921
  PubMedGoogle Scholar
• 13 PHLS . Outbreak of legionnaires' disease in Barrow-in-Furness.  Commun Dis Rep CDR Wkly. 2002;  12
  PubMedGoogle Scholar
• 14 Nakamura H, Yagyu H, Kishi K et al.. A large outbreak of legionnaires' disease due to an inadequate circulating and filtration system for bath water: epidemiologic manifestations.  Intern Med. 2003;  42 806-811
  PubMedGoogle Scholar
• 15 Jansa J M, Cayla J A, Ferrer D et al.. An outbreak of legionnaires' disease in an inner city district: importance of the first 24 hours in the investigation.  Int J Tuberc Lung Dis. 2002;  6 831-838
  PubMedGoogle Scholar
• 16 Benin A L, Benson R F, Arnold K E et al.. An outbreak of travel-associated legionnaires' disease and Pontiac fever: the need for enhanced surveillance of travel-associated legionellosis in the United States.  J Infect Dis. 2002;  185 237-243
  CrossrefPubMedGoogle Scholar
• 17 Den Boer J W, Yzerman E P, Schellekens J et al.. A large outbreak of legionnaires' disease at a flower show, the Netherlands, 1999.  Emerg Infect Dis. 2002;  8 37-43
  PubMedGoogle Scholar
• 18 Sax H, Dharan S, Pittet D. Legionnaires' disease in a renal transplant recipient: nosocomial or home grown?.  Transplantation. 2002;  74 890-892
  PubMedGoogle Scholar
• 19 Pedro-Botet M L, Stout J E, Yu V L. Legionnaires' disease contracted from patient homes: the coming of the third plague?.  Eur J Clin Microbiol Infect Dis. 2002;  21 699-705
  CrossrefPubMedGoogle Scholar
• 20 Franzin L, Scolfaro C, Cabodi D, Valera M, Tovo P A. Legionella pneumophila pneumonia in a newborn after water birth: a new mode of transmission.  Clin Infect Dis. 2001;  33 e103-104
  CrossrefPubMedGoogle Scholar
• 21 Skogberg K, Nuorti J P, Saxen H et al.. A newborn with domestically acquired legionnaires' disease confirmed by molecular typing.  Clin Infect Dis. 2002;  35 e82-85
  CrossrefPubMedGoogle Scholar
• 22 Cianciotto N P. Pathogenicity of Legionella pneumophila .  Int J Med Microbiol. 2001;  29 331-343
  PubMedGoogle Scholar
• 23 Steinert M, Hentschel U, Hacker J. Legionella pneumophila: an aquatic microbe goes astray.  FEMS Microbiol Rev. 2002;  26 149-162
  CrossrefPubMedGoogle Scholar
• 24 Sabria M, Yu V L. Hospital-acquired legionellosis: solutions for a preventable infection.  Lancet Infect Dis. 2002;  2 368-373
  CrossrefPubMedGoogle Scholar
• 25 Pedro-Botet M L, Sabria M, Sopena N et al.. Environmental legionellosis and oropharyngeal colonization Legionella in immunosuppressed patients.  Infect Control Hosp Epidemiol. 2002;  23 279-281
  PubMedGoogle Scholar
• 26 Benito J R, Montejo J M, Cancelo L et al.. Community-acquired pneumonia due to Legionella pneumophila serogroup 1: study of 97 cases.  Enferm Infec Microbiol Clin. 2003;  21 394-400
  PubMedGoogle Scholar
• 27 Bello L, Canle D, Sousa D et al.. Legionella pneumonia: description of a series of 42 cases (in Spanish). XI Spanish Congress of Infectious Diseases and Clinical Microbiology Society.  Enferm Infec Microbiol Clin. 2004;  22 51 , (P 141)
  PubMedGoogle Scholar
• 28 Sopena N, Sabriá-Leal M, Pedro-Botet M L et al.. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.  Chest. 1998;  113 1195-1200
  PubMedGoogle Scholar
• 29 Pascual J M, Redon J, Borras R et al.. Legionella pneumophila pneumonia: clinical characteristics of 52 cases.  Med Clin (Barc). 1987;  89 489-493
  PubMedGoogle Scholar
• 30 Greig J E, Carnie J A, Grahan F T et al.. An outbreak of legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies.  Med J Aust. 2004;  180 566-572
  PubMedGoogle Scholar
• 31 Fraser D W, Tsai T, Orenstein W et al.. Legionnaires' disease: description of an epidemic of pneumonia.  N Engl J Med. 1977;  297 1189-1197
  CrossrefPubMedGoogle Scholar
• 32 Kirby B D, Snyder K M, Meyer R D, Finegold S M. Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature.  Medicine (Baltimore). 1980;  59 188-205
  PubMedGoogle Scholar
• 33 Pedro-Botet M L, Sabriá-Leal M, Haro M et al.. Nosocomial and community-acquired Legionella pneumonia clinical comparative analysis.  Eur Respir J. 1995;  8 1929-1933
  CrossrefPubMedGoogle Scholar
• 34 Yu V L, Kroboth F J, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires' disease: new clinical perspective from a prospective pneumonia study.  Am J Med. 1982;  73 357-361
  CrossrefPubMedGoogle Scholar
• 35 Tan M J, Tan J S, Hamor R H et al.. The radiologic manifestations of legionnaires' disease. The Ohio Community-based pneumonia study group.  Chest. 2000;  117 398-403
  CrossrefPubMedGoogle Scholar
• 36 Torres A, Serra-Batlles J, Ferrer A et al.. Severe community-acquired pneumonia: epidemiology and prognostic factors.  Am Rev Respir Dis. 1991;  144 312-318
  CrossrefPubMedGoogle Scholar
• 37 Pachon J, Prados M D, Capote F, Cuello J A, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis, and treatment.  Am Rev Respir Dis. 1990;  142 369-373
  CrossrefPubMedGoogle Scholar
• 38 Falcó V, Fernandez de Sevilla T, Alegre J et al.. Legionella pneumophila: a cause of severe community-acquired pneumonias.  Chest. 1991;  100 1007-1011
  PubMedGoogle Scholar
• 39 Alvarez-Sanchez B, Alvarez-Lerma F, Jorda R, Serra J, Lopez-Cambra M J, Sandar M D. Prognostic factors and etiology in patients with severe community-acquired pneumonia admitted at the ICU. Spanish multicenter study. Study Group on Severe Community-Acquired Pneumonia in Spain].  Med Clin (Barc). 1998;  111 650-654
  PubMedGoogle Scholar
• 40 Pedro-Botet M L, Sabrià-Leal M, Sopena N et al.. Role of immunosuppression in the evolution of legionnaires' disease.  Clin Infect Dis. 1998;  26 14-19
  PubMedGoogle Scholar
• 41 Pedro-Botet M L, Sabrià M, Sopena N et al.. Legionnaires' disease and HIV infection.  Chest. 2003;  124 543-547
  CrossrefPubMedGoogle Scholar
• 42 Miller A C. Early clinical differentiation between legionnaires' disease and other sporadic pneumonias.  Ann Intern Med. 1979;  90 526-528
  PubMedGoogle Scholar
• 43 Granados A, Podzamczer D, Gudiol F et al.. Pneumonia due to L. pneumophila and pneumococcal pneumonia: similarities and differences on presentation.  Eur Respir J. 1989;  2 130-134
  PubMedGoogle Scholar
• 44 Helms C M, Viner J R, Sturu R H et al.. Comparative features of pneumococcal, Mycoplasma and Legionella pneumonia.  Ann Intern Med. 1979;  90 543-547
  PubMedGoogle Scholar
• 45 Olaechea P M, Quintana M M, Gallardo M S et al.. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.  Intensive Care Med. 1996;  22 1294-1300
  PubMedGoogle Scholar
• 46 Cunha B A. Clinical features of legionnaires' disease.  Semin Respir Infect. 1998;  13 116-127
  PubMedGoogle Scholar
• 47 Gupta S K, Imperiale T F, Sarosi G A. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia.  Chest. 2001;  120 1064-1071
  CrossrefPubMedGoogle Scholar
• 48 Alvarez J, Oyaga N, Escofet N, Codony F, Orcau A, Oliva J M. Leginelosis comunitaria en las comarcas de Barcelona entre 1992 y 1999: características epidemiológicas y métodos diagnósticos.  Med Clin (Barc). 2001;  117 495-496
  PubMedGoogle Scholar
• 49 Sopena N, Force L, Pedro-Botet M L et al.. Comparative study of Legionella pneumophila according to sporadic and outbreak presentation. 15th European Congress of Clinical Microbiology and Infectious Diseases.  Copenhagen. 2005;  85
  PubMedGoogle Scholar
• 50 Muder R, Stout J E, Yu V L, Nosocomial M D. Legionella micdadei infection in transplant patients: fortune favors the prepared mind.  Am J Med. 2000;  108 346-348
  CrossrefPubMedGoogle Scholar
• 51 Ta A C, Stout J, Yu V. Comparison of culture methods for monitoring Legionella species in hospital potable water systems and recommendations for standardization of such methods.  J Clin Microbiol. 1995;  33 2118-2123
  PubMedGoogle Scholar
• 52 Plouffe J F, File T M, Breiman R F et al.. Reevaluation of the definition of legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.  Clin Infect Dis. 1995;  20 1286-1291
  PubMedGoogle Scholar
• 53 Sopena N, Sabria M, Pedro-Botet M L et al.. Factors related to persistence of Legionella urinary antigen excretion in patients with legionnaires' disease.  Eur J Clin Microbiol Infect Dis. 2002;  21 845-848
  PubMedGoogle Scholar
• 54 Yu V L, Plouffe J F, Pastoris M C et al.. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey.  J Infect Dis. 2002;  186 127-128
  CrossrefPubMedGoogle Scholar
• 55 Dominguez J, Gali N, Matas L et al.. Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine simples.  Eur J Clin Microbiol Infect Dis. 1999;  18 896-898
  CrossrefPubMedGoogle Scholar
• 56 Murdoch D R, Walford E J, Jennings L C et al.. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia.  Clin Infect Dis. 1996;  23 475-480
  PubMedGoogle Scholar
• 57 Rantakokko-Jalaba K, Jalaba J. Development of conventional and real-time PCR assays for detection of Legionella DNA in respiratory specimens.  J Clin Microbiol. 2001;  39 2904-2910
  CrossrefPubMedGoogle Scholar
• 58 Edelstein P H. Antimicrobial chemotherapy for legionnaires' disease: a review.  Clin Infect Dis. 1995;  21 S265-S276
  PubMedGoogle Scholar
• 59 Meyer R D, Finegold S M. Legionnaires' disease.  Annu Rev Med. 1980;  31 219-232
  CrossrefPubMedGoogle Scholar
• 60 Hays J H, Hinthorn D R, Chonko A et al.. Failure of oral erythromycin therapy for legionnaires' disease in a renal transplant recipient.  South Med J. 1981;  74 1422-1423
  PubMedGoogle Scholar
• 61 Mercatello A, Frappaz D, Robert D et al.. Failure of erythromycin/rifampicin treatment of Legionella pneumonia.  J Infect. 1985;  10 282-283
  CrossrefPubMedGoogle Scholar
• 62 Rudin J E, Evans T L, Wing E J. Failure of erythromycin in treatment of Legionella micdadei pneumonia.  Am J Med. 1984;  76 318-320
  CrossrefPubMedGoogle Scholar
• 63 Stout J E, Arnold B, Yu V L. Comparative study of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by microdilution and intracellular susceptibility testing in HL-60 cells.  J Antimicrob Chemother. 1997;  41 289-291
  PubMedGoogle Scholar
• 64 Stout J, Arnold B, Yu V L. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.  J Antimicrob Chemother. 1998;  41 289-291
  CrossrefPubMedGoogle Scholar
• 65 Dubois J, St-Pierre C. In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species.  Clin Microbiol Infect. 1999;  5 205-212
  PubMedGoogle Scholar
• 66 Edelstein P H, Edelstein M AC. In vitro activity of the ketolide HMR 3647 (TU6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.  Antimicrob Agents Chemother. 1999;  43 90-95
  PubMedGoogle Scholar
• 67 Edelstein P H, Edelstein M AC. In vitro activity of azithromycin against clinical isolates of Legionella species.  Antimicrob Agents Chemother. 1991;  35 180-181
  PubMedGoogle Scholar
• 68 Fitzgeorge R B, Lever S, Baskerville A. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease.  J Antimicrob Chemother. 1993;  31(Suppl E) 171-176
  PubMedGoogle Scholar
• 69 Stamler D A, Edelstein M AC, Edelstein P H. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.  Antimicrob Agents Chemother. 1994;  38 217-222
  PubMedGoogle Scholar
• 70 Plouffe J F, Breiman R F, Fields B S et al.. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.  Clin Infect Dis. 2003;  37 1475-1480
  CrossrefPubMedGoogle Scholar
• 71 Edelstein P H, Edelstein M AC, Lehr K H et al.. In vitro activity of levofloxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.  J Antimicrob Chemother. 1996;  37 117-126
  CrossrefPubMedGoogle Scholar
• 72 Saito A, Sawatari K, Fukuda Y et al.. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.  Antimicrob Agents Chemother. 1985;  28 15-20
  PubMedGoogle Scholar
• 73 Stout J E, Arnold B, Yu V L. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.  Diagn Microbiol Infect Dis. 1998;  30 37-43
  CrossrefPubMedGoogle Scholar
• 74 Sabrià M, Yu V L. Legionella species (legionnaires' disease). In: Yu VL, Weber R, Raoult D Antimicrobial Therapy and Vaccines. 2nd ed. New York; Apple Trees Productions, LLC 2002: 395-417
  Google Scholar
• 75 Wynkel A, Toupance O, Melin J P et al.. Traitement des légionelloses par ofloxacine chez le transplant renal: abscence d'interférence avec la ciclosporine A.  Presse Med. 1991;  20 291-293
  PubMedGoogle Scholar
• 76 Mateu L, Pedro-Botet M L, Sopena N et al.. Fluoroquinolones in the treatment of community and hospital-acquired Legionella pneumonia (P 885). 15th European Congress of Clinical Microbiology and Infectious Diseases.  Copenhagen. 2005;  268
  PubMedGoogle Scholar
• 77 Salord J M, Matsiota-Bernard P, Staikowsky F et al.. Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone.  Clin Infect Dis. 1993;  17 518-519
  PubMedGoogle Scholar
• 78 Unertl K E, Lenhart F P, Forst H et al.. Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin.  Am J Med. 1989;  87(Suppl 5A) 128S-131S
  CrossrefPubMedGoogle Scholar
• 79 Kurz R W, Graninger W, Egger T P et al.. Failure of treatment of Legionella pneumophila with ciprofloxacin.  J Antimicrob Chemother. 1988;  22 389-391
  PubMedGoogle Scholar
• 80 Drusano G, Lebro M T, Cars O et al.. Pharmacokinetics and pharmacodynamics of fluoroquinolones.  Clin Microbiol Infect. 1998;  4(suppl 2) S27-S41
  PubMedGoogle Scholar
• 81 Baltch A L, Smith R P, Franke M A et al.. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. .  Antimicrob Agents Chemother. 1998;  42 3153-3156
  PubMedGoogle Scholar
• 82 Yu V L, Greenberg R N, Zadeikis N et al.. Levofloxacin efficacy in the treatment of community-acquired legionellosis.  Chest. 2004;  125 2135-2139
  CrossrefPubMedGoogle Scholar
• 83 Mykietiuk A, Carratalà J, Fernández-Sabé N et al.. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.  Clin Infect Dis. 2005;  40 794-799
  CrossrefPubMedGoogle Scholar
• 84 Blazquez Garrido R M, Espinosa Parra F J, Alemany Francés L et al.. Antimicrobial chemotherapy for legionnaires' disease: levofloxacin versus macrolides.  Clin Infect Dis. 2005;  40 800-806
  CrossrefPubMedGoogle Scholar
• 85 Sabrià M, Pedro-Botet M L, Gómez J for the Legionniares' Disease Therapy Group et al. Fluoroquinolones versus macrolides in the treatment of legionnaires' disease.  Chest. 2005;  128. 1401-1405
  CrossrefPubMedGoogle Scholar
• 86 Trubel H K, Meyer H G, Jahn B, Knuf M, Kamin W, Huth R G. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.  Scand J Infect Dis. 2002;  34 219-221
  PubMedGoogle Scholar
• 87 Stroup J S, Hendrickson S E, Neil M. Legionella pneumonia and HIV infection: a case report.  AIDS Read. 2004;  14 267-271
  PubMedGoogle Scholar
• 88 Martin S J, Pendland S L, Chen C, Schreckenberger P, Danzinger L H. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella .  Antimicrob Agents Chemother. 1996;  40 1419-1421
  PubMedGoogle Scholar
• 89 Martin S J, Pendland S L, Chen C, Schreckenberger P, Danzinger L H. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxyclarithromycin.  Diagn Microbiol Infect Dis. 1997;  29 167-171
  CrossrefPubMedGoogle Scholar
• 90 Marston B J, Lipman H B, Breiman R F. Surveillance for legionnaires' disease: risk factors for morbidity and mortality.  Arch Intern Med. 1994;  154 2417-2422
  CrossrefPubMedGoogle Scholar
• 91 Bollin G E, Plouffe J F, Para M F, Prior R B. Difference in virulence of environmental isolates of Legionella pneumophila. .  J Clin Microbiol. 1985;  21 674-677
  PubMedGoogle Scholar
• 92 Dennis P J, Lee J V. Differences in aerosol survival between pathogenic and nonpathogenic strains of Legionella pneumophila serogroup 1.  J Appl Bacteriol. 1988;  65 135-141
  PubMedGoogle Scholar
• 93 Summersgill J T, Raff M J, Miller R D. Interaction of virulent and avirulent Legionella pneumophila with human monocytes.  J Leukoc Biol. 1990;  47 31-38
  PubMedGoogle Scholar
• 94 Heath C H, Grove D I, Looke D FM. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality.  Eur J Clin Microbiol Infect Dis. 1996;  15 286-290
  CrossrefPubMedGoogle Scholar
• 95 Gacouin A, Le Tulzo Y, Lavoue S et al.. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy.  Intensive Care Med. 2002;  28 686-691
  CrossrefPubMedGoogle Scholar
• 96 Chow J W, Yu V L. Legionella: a major opportunistic pathogen in transplant recipients.  Semin Respir Infect. 1998;  13 132-139
  PubMedGoogle Scholar

M. Luisa Pedro-BotetM.D. 

Infectious Diseases Unit, Hospital Universitari Germans Trias I Pujol, Universitat Autònoma de Barcelona, Carretera del Canyet s/n, Badalona 08916, Barcelona, Spain

Email: mlpbotet@ns.hugtip.scs.es